Peptobiotics is pioneering a synthetic biology approach to develop alternatives to traditional livestock antibiotics, focusing on enhancing agricultural productivity while ensuring animal welfare and sustainability. Their innovative solution involves the use of recombinant peptides produced through a patent-pending precision fermentation process. This technology allows for the creation of a new class of feed additives that promote growth and protect against pathogens without contributing to antibiotic resistance. By leveraging advancements in human medicine and synthetic biology, Peptobiotics aims to deliver products that match the performance of conventional antibiotics while maximizing gut health and feed conversion in livestock and aquaculture.

The company employs a comprehensive discovery pipeline that integrates software, high-throughput screening, and rational design to engineer custom peptides tailored for specific livestock applications. Their production process is designed to be cost-competitive with traditional antibiotics, ensuring accessibility for farmers. The unique peptide sequences developed by Peptobiotics are engineered for efficacy, safety, and scalability, positioning the company as a leader in the development of sustainable feed additives. Through these technologies, Peptobiotics is committed to transforming the agricultural landscape by providing effective solutions that mitigate the risks associated with antibiotic use in animal husbandry.

Singapore

Peptobiotics is a synbio startup that develops livestock disease prevention biotechnology. By leveraging advances in human medicine and synthetic biology, they are creating a new class of feed additives that can maximize animal health.

20 Biopolis Way #B2-17, Centros Building. 138668

Peptobiotics

Company Details